Human Tumor-Derived p53 Mutants: A Growing Family of Oncoproteins
TP53 gene mutations are present in more than half of all human cancers. The resulting proteins are mostly full-length with a single amino acid change and are abundantly expressed in cancer cells. Some of the mutant p53 proteins gain oncogenic functions (GOF) through which it actively contribute to t...
Bewaard in:
Hoofdauteur: | Giovanni Blandino (auth) |
---|---|
Andere auteurs: | Ygal Haupt (auth) |
Formaat: | Elektronisch Hoofdstuk |
Taal: | Engels |
Gepubliceerd in: |
Frontiers Media SA
2016
|
Reeks: | Frontiers Research Topics
|
Onderwerpen: | |
Online toegang: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Gelijkaardige items
-
Vasculitis In Practice An Update on Special Situations - Clinical and Therapeutic Considerations
Gepubliceerd in: (2018) -
Cell Death Autophagy, Apoptosis and Necrosis
Gepubliceerd in: (2015) -
Targeting mutant p53 stabilization for cancer therapy
door: Jiajian Wang, et al.
Gepubliceerd in: (2023) -
Strategies for Molecularly Enhanced Chemotherapy to Achieve Synthetic Lethality in Endometrial Tumors with Mutant p53
door: Xiangbing Meng, et al.
Gepubliceerd in: (2013) -
Reactivation of mutant p53 in esophageal squamous cell carcinoma by isothiocyanate inhibits tumor growth
door: Lulu Guan, et al.
Gepubliceerd in: (2023)